The assay demonstrated excellent diagnostic performance, with AUROCs of 0.968 and 0.954 for L1CAM(+)‐NEVs and NCAM(+)‐NEVs, respectively, in distinguishing AD patients from HCs. This evidence concerns the gene L1CAM and Alzheimer disease.